Eagle Bay Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-80
| Closed | -$84.1K | – | 1040 |
|
|
2024
Q3 | $84.1K | Sell |
80
-1
| -1% | -$1.05K | 0.03% | 345 |
|
|
2024
Q2 | $85.1K | Sell |
81
-1
| -1% | -$1.05K | 0.05% | 256 |
|
|
2024
Q1 | $78.9K | Sell |
82
-2
| -2% | -$1.93K | 0.05% | 247 |
|
|
2023
Q4 | $73.8K | Sell |
84
-1
| -1% | -$878 | 0.05% | 250 |
|
|
2023
Q3 | $70K | Sell |
85
-1
| -1% | -$823 | 0.03% | 336 |
|
|
2023
Q2 | $61.8K | Buy |
86
+2
| +2% | +$1.44K | 0.04% | 328 |
|
|
2023
Q1 | $69K | Sell |
84
-5
| -6% | -$4.11K | 0.04% | 316 |
|
|
2022
Q4 | $64.2K | Sell |
89
-7
| -7% | -$5.05K | 0.04% | 325 |
|
|
2022
Q3 | $66K | Sell |
96
-6
| -6% | -$4.13K | 0.04% | 284 |
|
|
2022
Q2 | $60.3K | Buy |
+102
| New | +$60.3K | 0.04% | 315 |
|
|
2022
Q1 | – | Sell |
-109
| Closed | -$69K | – | 800 |
|
|
2021
Q4 | $69K | Sell |
109
-102
| -48% | -$64.6K | 0.04% | 267 |
|
|
2021
Q3 | $128K | Buy |
211
+105
| +99% | +$63.7K | 0.07% | 186 |
|
|
2021
Q2 | $61K | Buy |
+106
| New | +$61K | 0.05% | 275 |
|